Peter Greenleaf is Director of BIODELIVERY SCIENCES INTERNATIONAL INC. Currently has a direct ownership of 0 shares of BDSI, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2022, when has been sold 105,034 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Peter Greenleaf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2022
SELL
Other acquisition or disposition
-
105,034 Reduced 100.0%
0 Common Stock
Jan 27 2022
BUY
Exercise of conversion of derivative security
-
10,246 Added 8.89%
105,034 Common Stock
Aug 06 2021
BUY
Exercise of conversion of derivative security
-
35,000 Added 26.97%
94,788 Common Stock

Also insider at

AUPH
Aurinia Pharmaceuticals Inc. Healthcare
PG

Peter Greenleaf

Director
Victoria, A1

Track Institutional and Insider Activities on BDSI

Follow BIODELIVERY SCIENCES INTERNATIONAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSI shares.

Notify only if

Insider Trading

Get notified when an Biodelivery Sciences International Inc insider buys or sells BDSI shares.

Notify only if

News

Receive news related to BIODELIVERY SCIENCES INTERNATIONAL INC

Track Activities on BDSI